Park Ha Biological Technology
(NASDAQ) BYAH
Park Ha Biological Technology Financials at a Glance
Market Cap
$4.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
N/A
Net Income (TTM)
N/A
EPS (TTM)
-$41.38
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$0.75
Volume
62,217,629.259
Open
$0.72
Price
$0.75
Volume
62,217,629.259
Open
$0.72
Previous Close
$0.75
Daily Range
$0.69 - $1.02
52-Week Range
$0.69 - $2,068.60
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$0.75
Volume
62,217,629.259
Open
$0.72
Previous Close
$0.75
Daily Range
$0.69 - $1.02
52-Week Range
$0.69 - $2,068.60
Estimated Earnings Date
N/A
BYAH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Park Ha Biological Technology
Industry
Specialty Retail
Sector
Consumer DiscretionaryEmployees
41
CEO
Xiao Qiu Zhang
Website
www.parkha.cnHeadquarters
Wuxi, JS 214000, CN
BYAH Financials
Key Financial Metrics (TTM)
Gross Margin
91.21%
Operating Margin
-832.33%
Net Income Margin
-840.65%
Return on Equity
-652.67%
Return on Capital
-578.41%
Return on Assets
-447.35%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
6.06M
Volume
62.22M
Avg. Volume
3.49M
Financials (TTM)
Gross Profit
$2.89M
Operating Income
-$26.37M
EBITDA
-$26.14M
Operating Cash Flow
$6.06K
Capital Expenditure
-$132.13K
Free Cash Flow
-$126.07K
Cash & ST Invst.
$3.79M
Total Debt
$180.17K
Park Ha Biological Technology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.29M
N/A
Gross Profit
$1.11M
N/A
Gross Margin
86.16%
N/A
Market Cap
$4.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$139.55K
N/A
Employees
31
N/A
Net Income
-$4.53M
N/A
EBITDA
-$4.33M
N/A
Quarterly Fundamentals
Total Cash
$3.79M
+306.4%
Total Debt
$180.17K
+794.0%
Accounts Receivable
$1.30M
+86.7%
Inventory
$84.60K
-7.9%
Long Term Debt
$75.92K
+1610.6%
Short Term Debt
$104.25K
+563.4%
Return on Assets
-4.47%
N/A
Return on Invested Capital
-6.48%
N/A
Free Cash Flow
-$246.19K
N/A
Operating Cash Flow
-$159.58K
N/A